qiaamp dna blood mini kit (Qiagen)
99
Structured Review
Qiagen
qiaamp dna blood mini kit
Qiaamp Dna Blood Mini Kit, supplied by Qiagen, used in various techniques. Bioz Stars score: 99/100, based on 30565 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dna+blood+mini+kit/QIAamp+DNA+Blood+Mini+Kit/pm42891811-32-6-11
Average 99 stars, based on 30565 article reviews
Qiaamp Dna Blood Mini Kit, supplied by Qiagen, used in various techniques. Bioz Stars score: 99/100, based on 30565 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dna+blood+mini+kit/QIAamp+DNA+Blood+Mini+Kit/pm42891811-32-6-11
Average 99 stars, based on 30565 article reviews
qiaamp dna blood mini kit - by Bioz Stars,
2026-11
99/100 stars
Images
Related Articles
Analysis:Article Title: Prevalence of
<i>MUTYH</i>
germline variants in Pediatric and Adolescent/Young Adult Patients with a Brain Tumor Article Snippet: Background: Germline pathogenic and likely pathogenic variants (PV/LPV) in MutY DNA Glycosylase (MUTYH), a key gene in the Base Excision Repair (BER) pathway, are classically linked to MUTYH-associated polyposis (MAP) and colorectal cancer.. Emerging evidence suggests that MUTYH variants, particularly monoallelic ones, may contribute to susceptibility to other malignancies, including central nervous system (CNS) tumors.. Methods: We retrospectively analyzed 378 pediatric and adolescent/young adult (AYA) patients (222 males, 156 females) with CNS tumors diagnosed between 2011 and 2025. Blood/Plasma/Serum Samples:Article Title: Prevalence of
<i>MUTYH</i>
germline variants in Pediatric and Adolescent/Young Adult Patients with a Brain Tumor Article Snippet: Background: Germline pathogenic and likely pathogenic variants (PV/LPV) in MutY DNA Glycosylase (MUTYH), a key gene in the Base Excision Repair (BER) pathway, are classically linked to MUTYH-associated polyposis (MAP) and colorectal cancer.. Emerging evidence suggests that MUTYH variants, particularly monoallelic ones, may contribute to susceptibility to other malignancies, including central nervous system (CNS) tumors.. Methods: We retrospectively analyzed 378 pediatric and adolescent/young adult (AYA) patients (222 males, 156 females) with CNS tumors diagnosed between 2011 and 2025. Article Title: Carriage of the Laboratory of Genetics and Physiology Protein 2 Q425R Variant Reduces Liver Disease Severity in European Patients With Chronic Hepatitis Delta. Article Snippet: .. Genomic DNA was extracted from whole blood samples using a Article Title: Aberrant splicing caused by a homozygous AK2 c.498 + 1G > A variant in a patient with reticular dysgenesis and concurrent B-cell acute lymphoblastic leukemia. Article Snippet: Reticular dysgenesis (RD) is a rare autosomal recessive severe combined immunodeficiency characterized by profound neutropenia, T-cell lymphopenia and sensorineural hearing loss, and is caused by biallelic loss-of-function variants in AK2.. We identified a homozygous AK2 splice-site variant (c.498+1G>A) in a boy with RD and concurrent B-cell acute lymphoblastic leukemia (B-ALL), a clinical combination not previously reported in association with an AK2 variant.. An in vitro minigene assay showed that c.498+1G>A disrupts the canonical 5′ splice donor site and generates an aberrant transcript carrying a 4-bp intronic insertion after exon 5, which causes a frameshift and introduces a premature termination codon; the transcript is predicted to be degraded by nonsense-mediated mRNA decay or, if translated, to yield a non-functional truncated protein, leading to loss of AK2 function. other:Article Title: Polycationic polymers for use in treating and detecting cancer Article Snippet: Just prior to sacrifice, caudal vena cava blood was collected from each mouse for analysis of plasma cfDNA levels using Picogreen staining (Invitrogen). DNA Extraction:Article Title: TAG-CLL, a Novel Tagmentation-Based Approach to Somatic Hypermutation Testing of IGHV Reveals the Weak Points of Both Sanger and Next-Generation Sequencing Methods. Article Snippet: From the Department of Hematology,* University Clinical Hospital in Rzeszow, Rzeszow; the Department of Hematology, † College of Medical Sciences, University of Rzeszow, Rzeszow; the Department of Experimental Hematooncology, ‡ Medical University of Lublin, Lublin; the Department of Hematology, § Poznan University of Medical Sciences, Pozna�n; the Department of Hematology, ¶ University Clinical Hospital in Szczecin, Szczecin; the Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, ‖ Polish Academy of Sciences, Wroclaw; the Department of Hematology and Cellular Transplantation,** Lower Silesian Oncology Center, Wroclaw; the Faculty of Medicine, †† Wroclaw University of Science and Technology, Wroclaw; the Department of Hematology, ‡‡ Nicolaus Copernicus Memorial Provincial Specialist Hospital in Lodz, Lodz; the Department of Hematological Diagnostics and Genetics, §§ Jagiellonian University Hospital in Krakow, Krakow; the Laboratory of Hematological Diagnostics, ¶¶ Institute of Hematology and Transfusion Medicine, Warsaw; Oncogene Diagnostics Inc., ‖‖ Krakow; the Department of Molecular Diagnostics,*** Holy Cross Cancer Center, Kielce; the Division of Medical Biology, ††† Institute of Biology Jan Kochanowski University, Kielce; the Laboratory of Molecular Genetics and Cytogenetics, ‡‡‡ Warsaw Medical University, Warsaw; the Maria Sklodowska-Curie National Research Institute of Oncology, §§§ Warsaw; the Clinical Department of Haematology, Blood Neoplasms and Bone Marrow Transplantation, ¶¶¶ Wroclaw Medical University, Wroclaw; and the Department of Clinical Genetics, ‖‖‖ Nicolaus Copernicus University Ludwik Rydygier Collegium Medicum, Bydgoszcz, Poland Polymerase Chain Reaction:Article Title: TAG-CLL, a Novel Tagmentation-Based Approach to Somatic Hypermutation Testing of IGHV Reveals the Weak Points of Both Sanger and Next-Generation Sequencing Methods. Article Snippet: From the Department of Hematology,* University Clinical Hospital in Rzeszow, Rzeszow; the Department of Hematology, † College of Medical Sciences, University of Rzeszow, Rzeszow; the Department of Experimental Hematooncology, ‡ Medical University of Lublin, Lublin; the Department of Hematology, § Poznan University of Medical Sciences, Pozna�n; the Department of Hematology, ¶ University Clinical Hospital in Szczecin, Szczecin; the Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, ‖ Polish Academy of Sciences, Wroclaw; the Department of Hematology and Cellular Transplantation,** Lower Silesian Oncology Center, Wroclaw; the Faculty of Medicine, †† Wroclaw University of Science and Technology, Wroclaw; the Department of Hematology, ‡‡ Nicolaus Copernicus Memorial Provincial Specialist Hospital in Lodz, Lodz; the Department of Hematological Diagnostics and Genetics, §§ Jagiellonian University Hospital in Krakow, Krakow; the Laboratory of Hematological Diagnostics, ¶¶ Institute of Hematology and Transfusion Medicine, Warsaw; Oncogene Diagnostics Inc., ‖‖ Krakow; the Department of Molecular Diagnostics,*** Holy Cross Cancer Center, Kielce; the Division of Medical Biology, ††† Institute of Biology Jan Kochanowski University, Kielce; the Laboratory of Molecular Genetics and Cytogenetics, ‡‡‡ Warsaw Medical University, Warsaw; the Maria Sklodowska-Curie National Research Institute of Oncology, §§§ Warsaw; the Clinical Department of Haematology, Blood Neoplasms and Bone Marrow Transplantation, ¶¶¶ Wroclaw Medical University, Wroclaw; and the Department of Clinical Genetics, ‖‖‖ Nicolaus Copernicus University Ludwik Rydygier Collegium Medicum, Bydgoszcz, Poland Automatic:Article Title: TAG-CLL, a Novel Tagmentation-Based Approach to Somatic Hypermutation Testing of IGHV Reveals the Weak Points of Both Sanger and Next-Generation Sequencing Methods. Article Snippet: From the Department of Hematology,* University Clinical Hospital in Rzeszow, Rzeszow; the Department of Hematology, † College of Medical Sciences, University of Rzeszow, Rzeszow; the Department of Experimental Hematooncology, ‡ Medical University of Lublin, Lublin; the Department of Hematology, § Poznan University of Medical Sciences, Pozna�n; the Department of Hematology, ¶ University Clinical Hospital in Szczecin, Szczecin; the Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, ‖ Polish Academy of Sciences, Wroclaw; the Department of Hematology and Cellular Transplantation,** Lower Silesian Oncology Center, Wroclaw; the Faculty of Medicine, †† Wroclaw University of Science and Technology, Wroclaw; the Department of Hematology, ‡‡ Nicolaus Copernicus Memorial Provincial Specialist Hospital in Lodz, Lodz; the Department of Hematological Diagnostics and Genetics, §§ Jagiellonian University Hospital in Krakow, Krakow; the Laboratory of Hematological Diagnostics, ¶¶ Institute of Hematology and Transfusion Medicine, Warsaw; Oncogene Diagnostics Inc., ‖‖ Krakow; the Department of Molecular Diagnostics,*** Holy Cross Cancer Center, Kielce; the Division of Medical Biology, ††† Institute of Biology Jan Kochanowski University, Kielce; the Laboratory of Molecular Genetics and Cytogenetics, ‡‡‡ Warsaw Medical University, Warsaw; the Maria Sklodowska-Curie National Research Institute of Oncology, §§§ Warsaw; the Clinical Department of Haematology, Blood Neoplasms and Bone Marrow Transplantation, ¶¶¶ Wroclaw Medical University, Wroclaw; and the Department of Clinical Genetics, ‖‖‖ Nicolaus Copernicus University Ludwik Rydygier Collegium Medicum, Bydgoszcz, Poland Sequencing:Article Title: TAG-CLL, a Novel Tagmentation-Based Approach to Somatic Hypermutation Testing of IGHV Reveals the Weak Points of Both Sanger and Next-Generation Sequencing Methods. Article Snippet: From the Department of Hematology,* University Clinical Hospital in Rzeszow, Rzeszow; the Department of Hematology, † College of Medical Sciences, University of Rzeszow, Rzeszow; the Department of Experimental Hematooncology, ‡ Medical University of Lublin, Lublin; the Department of Hematology, § Poznan University of Medical Sciences, Pozna�n; the Department of Hematology, ¶ University Clinical Hospital in Szczecin, Szczecin; the Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, ‖ Polish Academy of Sciences, Wroclaw; the Department of Hematology and Cellular Transplantation,** Lower Silesian Oncology Center, Wroclaw; the Faculty of Medicine, †† Wroclaw University of Science and Technology, Wroclaw; the Department of Hematology, ‡‡ Nicolaus Copernicus Memorial Provincial Specialist Hospital in Lodz, Lodz; the Department of Hematological Diagnostics and Genetics, §§ Jagiellonian University Hospital in Krakow, Krakow; the Laboratory of Hematological Diagnostics, ¶¶ Institute of Hematology and Transfusion Medicine, Warsaw; Oncogene Diagnostics Inc., ‖‖ Krakow; the Department of Molecular Diagnostics,*** Holy Cross Cancer Center, Kielce; the Division of Medical Biology, ††† Institute of Biology Jan Kochanowski University, Kielce; the Laboratory of Molecular Genetics and Cytogenetics, ‡‡‡ Warsaw Medical University, Warsaw; the Maria Sklodowska-Curie National Research Institute of Oncology, §§§ Warsaw; the Clinical Department of Haematology, Blood Neoplasms and Bone Marrow Transplantation, ¶¶¶ Wroclaw Medical University, Wroclaw; and the Department of Clinical Genetics, ‖‖‖ Nicolaus Copernicus University Ludwik Rydygier Collegium Medicum, Bydgoszcz, Poland Hi-C:Article Title: Candidate genes underlying hypomelanistic morphs in squamate reptiles Article Snippet: .. DNA was extracted using the Whole-Exome Sequencing:Article Title: Aberrant splicing caused by a homozygous AK2 c.498 + 1G > A variant in a patient with reticular dysgenesis and concurrent B-cell acute lymphoblastic leukemia. Article Snippet: Reticular dysgenesis (RD) is a rare autosomal recessive severe combined immunodeficiency characterized by profound neutropenia, T-cell lymphopenia and sensorineural hearing loss, and is caused by biallelic loss-of-function variants in AK2.. We identified a homozygous AK2 splice-site variant (c.498+1G>A) in a boy with RD and concurrent B-cell acute lymphoblastic leukemia (B-ALL), a clinical combination not previously reported in association with an AK2 variant.. An in vitro minigene assay showed that c.498+1G>A disrupts the canonical 5′ splice donor site and generates an aberrant transcript carrying a 4-bp intronic insertion after exon 5, which causes a frameshift and introduces a premature termination codon; the transcript is predicted to be degraded by nonsense-mediated mRNA decay or, if translated, to yield a non-functional truncated protein, leading to loss of AK2 function. |